Plain-English translation of NCT05770687 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a real-world study of SGLT2 inhibitors, a class of diabetes medication, in people who have experienced a heart attack and received a stent procedure. Researchers want to understand how well this medication helps the heart recover and function after a heart attack. The study will follow 1,000 newly treated patients and compare them to 3,000 similar patients from past records.
Heart attacks are particularly serious for people with type 2 diabetes, and doctors want to know whether this medication—already known to help the heart in some ways—can improve recovery and prevent further damage to heart muscle in this specific group of patients.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be tracked over time, and your medical records—including information about your heart function, medications, and recovery—will be collected and analyzed. The research team at one of eight hospitals in South Korea will monitor your progress and compare your outcomes to similar patients from previous studies. You will not need to take a new medication; instead, researchers will observe how the you are already taking affects your heart health.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
South Korea
Collaborators
Seoul St. Mary's Hospital, Uijeongbu St. Mary Hospital
Enrollment target
~1,000 participants
Started
August 2020
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
19 Years and older
Last updated on clinicaltrials.gov in January 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Kiyuk Chang, MD, PhD
Seoul St. Mary's Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.